Anti-Rift Valley Fever Virus, Glycoprotein (Gc) (Clone RVFV-128)-Purified No Carrier Protein, Clone: [RVFV-128], Monoclonal
Biozol Catalog Number:
ABI-12-8244
Supplier Catalog Number:
12-8244
Alternative Catalog Number:
ABI-12-8244-1MG
Manufacturer:
Abeomics
Category:
Antikörper
Application:
ELISA
Specificity: Clone RVFV-128 binds a unique epitope of the fusion loop adjacent to domain II (DII) of the Gc glycoprotein of Rift Valley Fever Virus (RVFV). Antigen Distribution: RVFV is primarily found in hepatic cells, endothelial cells, and mononuclear phagocytes in the human body. This distribution reflects the viruss tendency to cause hepatitis, hemorrhagic fever, and encephalitis during infection. Background: RVFV is a mosquito-borne phlebovirus primarily found in sub-Saharan Africa, especially in eastern and southern Africa. It infects both humans and ungulates (such as cows, goats, and sheep). RVFV causes a wide range of health effects, from mild illness to severe conditions like hemorrhagic disease, encephalitis, hepatitis, kidney injury, and retinitis. The virus can lead to spontaneous abortions in animals. RVFV outbreaks often occur during years of unusually heavy rainfall and flooding, as mosquitoes hatch more eggs, increasing transmission potential1,2. RVFV-128 is a monoclonal antibody that specifically recognizes a unique epitope of the fusion loop adjacent to domain II (DII) of the Gc glycoprotein of Rift Valley Fever Virus (RVFV).
Clonality:
Monoclonal
Clone Designation:
[RVFV-128]
Purity:
Purity: >=90% monomer by analytical SEC and SDS-Page Preparation: Recombinant antibodies are manufactured in an animal free facility using only in vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Target:
Glycoprotein (Gc)
Application Dilute:
ELISA, N
* VAT and and shipping costs not included. Errors and price changes excepted
